Lionco Pharmaceutical Group Co.,Ltd. (SHA:603669)

China flag China · Delayed Price · Currency is CNY
4.630
+0.070 (1.54%)
Feb 4, 2026, 3:00 PM CST
-14.89%
Market Cap3.26B -7.2%
Revenue (ttm)430.61M +55.3%
Net Income-118.38M
EPS-0.16
Shares Out703.54M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,899,500
Average Volume9,326,403
Open4.570
Previous Close4.560
Day's Range4.550 - 4.640
52-Week Range3.450 - 7.050
Beta0.34
RSI44.01
Earnings DateApr 25, 2026

About SHA:603669

Lionco Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products and medical services in China. It offers chemical and prescription drugs for nutrition, antimicrobial, antiviral, digestive, cardiovascular, cerebrovascular, detoxification, anti-tumor, and other applications. The company was founded in 2003 and is based in Shannan, China. [Read more]

Sector Healthcare
Founded 2003
Employees 436
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603669
Full Company Profile

Financial Performance

In 2024, SHA:603669's revenue was 379.78 million, an increase of 92.95% compared to the previous year's 196.83 million. Losses were -130.76 million, -13.68% less than in 2023.

Financial Statements